242
Views
13
CrossRef citations to date
0
Altmetric
Articles

Purified Dry Paullinia cupana (PC-18) Extract for Chemotherapy-Induced Fatigue: Results of Two Double-Blind Randomized Clinical Trials

, MD, , MD, (Medical Student) , , PhD, , PhD, , PhD, , PhD, , PhD & , PhD show all

References

  • Araujo JKL, Giglio AD, Munhoz BA, Fonseca FLA, Cruz FM, Giglio AD. 2016. Chemotherapy-Induced Fatigue Correlates With Higher Fatigue Scores Before Treatment. Am J Hosp Palliat Care. 3(5):404–411. doi:10.1177/1049909116629134.
  • Campos M, Hassan BJ, Riechelmann R, Del Giglio A. 2011. Cancer-related fatigue: a practical review. Ann Oncol. 22:1273–79. doi:10.1093/annonc/mdq458. PMID:21325448.
  • Carroll D, Ring C, Suter M, Willemsen G. 2000. The effects of an oral multivitamin combination with calcium, magnesium, and zinc on psychological well-being in healthy young male volunteers: a double-blind placebo-controlled trial. Psychopharmacology. 150:220–25. doi:10.1007/s002130000406. PMID:10907676.
  • Cho HJ, Costa E, Menezes PR, Chalder T, Bhugra D, Wessely S. 2007. Cross-cultural validation of the Chalder Fatigue Questionnaire in Brazilian primary care. J Psychosom Res. 62:301–04. doi:10.1016/j.jpsychores.2006.10.018. PMID:17324680.
  • Cruz FM, Munhoz BA, Alves BC, Gehrke FS, Fonseca FL, Kuniyoshi RK, Cubero D, Peppone LJ, Del Giglio A. 2015. Biomarkers of fatigue related to adjuvant chemotherapy for breast cancer: evaluation of plasma and lymphocyte expression. Clin Transl Med. 4:4. doi:10.1186/s40169-015-0051-8. PMID:25852820.
  • de Oliveira Campos MP, Riechelmann R, Martins LC, Hassan BJ, Casa FB, Del Giglio A. 2011. Guarana (Paullinia cupana) improves fatigue in breast cancer patients undergoing systemic chemotherapy. J Altern Complement Med. 17:505–12. doi:10.1089/acm.2010.0571. PMID:21612429.
  • del Giglio AB, Cubero Dde I, Lerner TG, Guariento RT, de Azevedo RG, Paiva H, Goldman C, CarelliB, Cruz FM, Schindler F, et al. 2013. Purified dry extract of Paullinia cupana (guaraná) (PC-18) for chemotherapy-related fatigue in patients with solid tumors: an early discontinuation study. J Diet Suppl. 10:325–34. doi:10.3109/19390211.2013.830676. PMID:24237188.
  • Gamelin L, Boisdron-Celle M, Delva R, Guérin-Meyer V, Ifrah N, Morel A, Gamelin E. 2004. Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer. Clin Cancer Res. 10:4055–61. doi:10.1158/1078-0432.CCR-03-0666. PMID:15217938.
  • Kennedy DO, Haskell CF, Robertson B, Reay J, Brewster-Maund C, Luedemann J, Maggini S, Ruf M, Zangara A, Scholey AB. 2008. Improved cognitive performance and mental fatigue following a multi-vitamin and mineral supplement with added guarana (Paullinia cupana). Appetite. 50:506–13. doi:10.1016/j.appet.2007.10.007. PMID:18077056.
  • Marcon R, Del Giglio A, Pianowski LF, Calixto JB. 2011. An analysis of the role of Paullinia cupana (Guaraná) in blood IL-1b and brain IL-6 levels as well as brain IL-6 and TNF-a mRNA expression in mice. J Clin Oncol. 29:e21002. doi:10.1200/jco.2011.29.15_suppl.e21002.
  • Osswald H, Schnermann J. 2011. Methylxanthines and the kidney. In: Methylxanthines. Handb Exp Pharmacol. 200:391–412. Heidelberg, Berlin: Springer. doi:10.1007/978-3-642-13443-2_15. PMID:20859805.
  • Park H, Parker GL, Boardman CH, Morris MM, Smith TJ. 2011. A pilot phase II trial of magnesium supplements to reduce menopausal hot flashes in breast cancer patients. Support Care Cancer. 19:859–63. doi:10.1007/s00520-011-1099-7. PMID:21271347.
  • Smith N, Atroch AL. 2010. Guarana's journey from regional tonic to aphrodisiac and global energy drink. Evid Based Complement Alternat Med. 7:279–82. http://www.hindawi.com/journals/ecam/2010/217062/abs/. doi:10.1093/ecam/nem162. PMID:18955289.
  • The University of Texas MD Anderson Cancer Center, State of Texas. Symptom Research—The Brief Fatigue Inventory (BFI) | MD Anderson Cancer Center. http://www.mdanderson.org/education-and-research/departments-programs-and-labs/departments-and-divisions/symptom-research/symptom-assessment-tools/brief-fatigue-inventory-bfi.html
  • U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. 2009. Common terminology criteria for adverse events (CTCAE) version 4.0. National Institutes of Health, National Cancer Institute. 4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.